Some peptides are exciting because they are new. GHK-Cu is exciting for the opposite reason: researchers have been studying it for half a century, and its biology continues to span an unusually broad range of processes. That combination — a long history and a wide reach — makes it one of the most instructive molecules to understand in peptide science.
A molecule the body already makes
The tripeptide glycyl-L-histidyl-L-lysine — GHK — was described by Loren Pickart in 1973, and it announced itself with a striking observation: it circulates at higher levels in young people than in older ones, and it could make aged tissue behave, in the lab, more like young tissue. GHK binds copper with high affinity, and the copper-bound form, GHK-Cu, carries much of its biological activity. Copper is an essential partner for the enzymes that build and remodel skin, which is one reason this molecule keeps appearing wherever the body is repairing itself.
What decades of research have shown
The repair biology is where the evidence is richest and most consistent. Across laboratory and animal studies compiled in Pickart and Margolina’s reviews, GHK-Cu has been reported to speed wound closure, support the survival of skin grafts, activate the fibroblasts that lay down the dermal scaffold, and encourage angiogenesis — the growth of new blood vessels into healing tissue. At the level of gene expression, it turns up production of collagen, elastin, and the cushioning molecules of the skin’s matrix while tuning the enzymes that break them down. The picture that emerges is of a molecule that nudges tissue toward building and renewing.
One analysis ran GHK’s signature through a large gene-expression database and reported that it shifted a substantial fraction of human genes, moving many toward a more youthful pattern — a finding that helps explain why researchers find the peptide’s reach so notable. That result is a gene-expression signal, and worth reading as one.
For skin specifically, the biology connects to human evidence. Controlled cosmetic studies of GHK-Cu formulations — including a 12-week facial-cream study in women with photoaged skin — reported measurable improvements in skin density, firmness, clarity, and the appearance of fine lines and wrinkles, and in one comparison GHK-Cu increased collagen in a majority of volunteers. These are appearance-level results in topical use, and they help explain why GHK-Cu has become an established ingredient in advanced skincare formulations.
What is still being explored
The evidence is not equally developed across every proposed use. Topical cosmetic applications have some direct human data behind them, while broader systemic claims rely much more heavily on mechanistic, cell, and animal research.
The open questions are about how far this reach extends. Much of GHK-Cu’s broader promise — in systemic repair, protection against age-related decline, and regenerative medicine — rests today on mechanism and animal work, with human research still catching up. For a molecule with this depth of history, that is less a caveat than an invitation to keep studying it.
Why it matters
GHK-Cu is a reminder that some of the most interesting biology is hiding in plain sight — in a peptide our own bodies have used all along. Fifty years in, it remains a rich case study in the science of repair, skin, and aging, with a well-established topical story and plenty still to learn about the rest.